MedPath

Impact of Marketing of Alcohol Products on Young People

Not Applicable
Completed
Conditions
Alcoholism
Interventions
Device: MRI
Behavioral: Alcohol Use Disorders Identification Test
Registration Number
NCT03818750
Lead Sponsor
Rennes University Hospital
Brief Summary

Impact of marketing of alcohol products on young people

Detailed Description

Responsible for 3.3 million deaths worldwide, alcohol consumption causes diseases (liver cirrhosis, cancers, etc.) and social problems (injuries, road accidents, alcohol dependence, etc.). With one of the highest consumption rate in Europe, alcohol is the second cause of avoidable mortality in France after tobacco (49.000 alcohol attributable deaths in 2009) and its social cost is estimated to 120 billion euros. French teenage population is particularly associated with heavy drinking patterns: in 2014, 49% of 17-year olds declared heavy episodic drinking.

In that regard, several measures are recommended by health actors to combat this issue: minimum unit pricing, sales ban to minor, low blood alcohol concentration for drivers, etc. A specific measure concerns alcohol advertising restrictions. Some countries implemented alcohol advertising regulation laws (Poland, Sweden, Finland, Estonia, etc.), including France with the Evin law passed in 1991. This French law mandates advertising (and packaging) content to strictly convey factual information and objective qualities of alcohol products and thus bans attractive ads based on image and lifestyle evocations (seduction, power, etc.).

The objective of this research is to investigate whether statutory framework for alcohol advertising (e.g., Evin law) can effectively protect people against misleading, suggestive, and appealing content. Little research has been conducted on this topic in spite of WHO's recommendations (most research has explored the influence of exposure to ads but not the impact of content).

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
78
Inclusion Criteria
  • volunteer males
  • aged 18-25
  • right-handed
  • persons that consume alcohol : " light drinkers " or "heavy drinkers" (defined with the AUDIT scale, scores between 1 to 7)
  • written consent and agreement consent will be given
  • Affiliated to the French social insurance
Exclusion Criteria
  • color-blind persons
  • misuse of psychoactive products (except tobacco) (cannabis : no regular consumers -more than 10 times per month ; no users of other illicit drugs - even for occasional consumption)
  • non fluent french speaking persons (people who couldn't understand instructions or asked questions)
  • persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Related to the MRI:

  • Cardiac pacemaker or implanted defibrillator
  • Cochlear implant
  • Peripheral or neuronal stimulator
  • Intra-ocular or brain metallic foreign bodies
  • Any other contraindications to MRI

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Experimental armMRIPatients (60) will be selected from the Alcohol Use Disorders Identification Test (AUDIT-C) : * "light drinkers" (score between 1 to 3) * "heavy drinkers" (score between 4 to 7) Two clinical visits will be realized in less than 4 weeks
Experimental armAlcohol Use Disorders Identification TestPatients (60) will be selected from the Alcohol Use Disorders Identification Test (AUDIT-C) : * "light drinkers" (score between 1 to 3) * "heavy drinkers" (score between 4 to 7) Two clinical visits will be realized in less than 4 weeks
Primary Outcome Measures
NameTimeMethod
Changes in brain activation in areas involved in the control of reward and motivation when looking at neutral versus contextual adsMonth 1

Significant change in cerebral activity (expressed as a significant variation in hemodynamic response BOLD) in the condition of alcohol ads with versus without context (party, sport, people) in areas involved in the control of reward and motivation (striatum dorsal, insula)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Rennes

🇫🇷

Rennes, France

© Copyright 2025. All Rights Reserved by MedPath